Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Saxagliptin on Endothelial Function in Patients With Type 2 Diabetes
2010-018979-16Phase 3Completed
- Sponsor
- University Hospital Erlangen
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Saxagliptin with Placebo (2 arms). Primary endpoint: Change of retinal capillary flow in response to L-NMMA. Started May 2010; status: completed.
02
Drugs
saxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2010-018979-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018979-16.